#opk

4 months ago

#OPK OPKO Health Reports Third Quarter 2025 Business Highlights and Financial Results

www.stocktitan.net/news/OPK/opko-health-rep...

0 0 0 0

OPKO Health’s ModeX Therapeutics Enters into Research Collaboration with Regeneron to Develop Multispecific Antibodies for Select Therapeutic Indications ModeX Therapeutics (NASDAQ: OPK) announced a license and collaboration with Regeneron (NASDAQ: REGN) to discover and develop multispecific antibodies using ModeX’s MSTAR platform and Regeneron’s proprietary binders.Key terms: an upfront payment of $7 million, per-molecule product selection, clinical and commercial milestone payments exceeding $200 million per selected molecule, tiered global net sales royalties up to the low double digits, and an overall collaboration value that potentially exceeds $1 billion if multiple products advance. Regeneron will fund and lead preclinical, clinical development and commercialization for products it advances. Targeted indications include immunology, oncology and metabolic diseases.

4 months ago

#OPK OPKO Health’s ModeX Therapeutics Enters into Research Collaboration with Regeneron to Develop Multispecific Antibodies for Select Therapeutic Indications

www.stocktitan.net/news/OPK/opko-health-s-m...

0 0 0 0

OPKO Health’s ModeX Therapeutics Begins Clinical Trial of MDX2004 for the Treatment of Advanced Cancers ModeX Therapeutics Inc., an OPKO Health company (NASDAQ:

4 months ago

#OPK OPKO Health’s ModeX Therapeutics Begins Clinical Trial of MDX2004 for the Treatment of Advanced Cancers

www.stocktitan.net/news/OPK/opko-health-s-m...

0 0 0 0

HBIC of Nonsense

@donotgoquietly2025.bsky.social

6 months ago

#AltCitizens needed!

Sent out by Boots On the Ground.

#OverlandPark
#OPK
#JoCo
#FuckICE

28 22 6 2

OPKO Health Reports Second Quarter 2025 Business Highlights and Financial Results OPKO Health (NASDAQ: OPK) reported Q2 2025 financial results with total revenues of $156.8 million, down from $182.2 million in Q2 2024. The company posted a net loss of $148.4 million ($0.19 per share), including a $91.7 million non-recurring expense related to convertible note exchange.Key developments include Merck's advancement of Phase 1 Epstein-Barr virus vaccine trial, ModeX's progress in immuno-oncology portfolio, and promising preclinical data for OPK-88006 in diabetes treatment. The FDA approved a supplemental application for the 4KScore® Test, and the Board authorized an additional $100 million for stock repurchase, bringing total capacity to $200 million.The Pharmaceuticals segment generated $40.7 million in product revenue, while Diagnostics revenue was $101.1 million. Cash position stood at $285.4 million as of June 30, 2025.

7 months ago

#OPK OPKO Health Reports Second Quarter 2025 Business Highlights and Financial Results

www.stocktitan.net/news/OPK/opko-health-rep...

0 0 0 0

Breakthrough: First-Ever Oral Tablet Could Replace Daily Injections for Short Bowel Syndrome Treatment Novel oral GLP-2 tablet aims to revolutionize Short Bowel Syndrome treatment, potentially replacing daily injections. Key clinical data to be presented. See breakthrough details.

8 months ago

#OPK OPKO Health and Entera Bio Announce Abstract on PK/PD of Oral GLP-2 Tablet for the Treatment of Short Bowel Syndrome Selected for 2025 ESPEN Congress

www.stocktitan.net/news/OPK/opko-health-and...

0 0 0 0

NextPlat Issues Interim CEO Update Shareholder Letter NextPlat (NASDAQ: NXPL) has issued an interim CEO update following the unexpected passing of former CEO Charles M. Fernandez. Interim CEO David Phipps outlined the company's strategic direction, focusing on two main divisions: Healthcare and E-Commerce.In the Healthcare division, which represents the largest part of their business, NextPlat plans to expand contracted 340B and long-term care services, implement operational efficiencies, and pursue specialty medication accreditation. Key initiatives include exploring nationwide licensing for e-Commerce mail-order sales, adding compounding services, and targeting non-insured cash sales.For the E-Commerce division, despite facing challenges from U.S.-China tariffs affecting product launches like their Florida Sunshine vitamin brand, the company aims to scale globally through strategic acquisitions, new marketplace launches, and partnerships. Notable developments include expanding their partnership with OPKO Health (NASDAQ: OPK) for health product sales in China and exploring UK/EU markets for their vitamin brand.The company has also committed to implementing a previously announced stock buyback program and improving shareholder transparency while focusing on generating positive operating results.

8 months ago

#NXPL #NXPLW #OPK NextPlat Issues Interim CEO Update Shareholder Letter

www.stocktitan.net/news/NXPL/next-plat-issu...

0 0 0 0

OPKO Health Reports First Quarter 2025 Business Highlights and Financial Results OPKO Health reports Q1 2025 financial results with key developments in its business portfolio. The company signed a definitive agreement to sell BioReference's oncology testing assets to Labcorp for up to $225 million. OPKO partnered with Entera Bio to develop an oral GLP-1/glucagon tablet for obesity treatment, with OPKO holding a 60% stake. Financial highlights include consolidated revenues of $149.9 million, down from $173.7 million in Q1 2024. The company posted a net loss of $67.6 million ($0.10 per share), improving from $81.8 million ($0.12 per share) year-over-year. Notable progress includes Merck's Phase 1 trial of an Epstein-Barr virus vaccine and ModeX's advancement of four clinical candidates. The Board authorized an additional $100 million for stock repurchase, bringing total capacity to $200 million. Cash position stands strong at $449.7 million as of March 31, 2025.

10 months ago

#OPK OPKO Health Reports First Quarter 2025 Business Highlights and Financial Results

www.stocktitan.net/news/OPK/opko-health-rep...

0 0 0 0

OPKO Health Unleashes Massive $200M Stock Buyback Plan, Targets 14% of Shares Major expansion of share repurchase program signals management confidence. Already $41M executed, with capacity for 14% of outstanding shares. See full analysis.

11 months ago

#OPK OPKO Health Announces $100 Million Increase to its Existing Share Repurchase Program

www.stocktitan.net/news/OPK/opko-health-ann...

0 0 0 0

Revolutionary Oral GLP-1 Obesity Treatment: OPKO and Entera Bio Join Forces for Game-Changing Pill First-in-class oral GLP-1/glucagon tablet shows promising early data. OPKO takes 60% stake in development program targeting $100B+ obesity market, IND filing planned for 2025.

1 year ago

#OPK OPKO Health and Entera Bio Enter into Collaboration Agreement to Advance Oral GLP-1/Glucagon Tablet Candidate into the Clinic to Treat Obesity and Metabolic Disorders

www.stocktitan.net/news/OPK/opko-health-and...

0 0 0 0

Labcorp's $225M Oncology Testing Expansion: Strategic BioReference Assets Acquisition Promises Market Growth Labcorp expands oncology diagnostics portfolio through $225M acquisition of BioReference Health assets, adding $85-100M annual revenue and strengthening market leadership in cancer testing.

1 year ago

#LH #OPK Labcorp Announces Acquisition of Select Assets of BioReference Health's Innovative Oncology and Related Clinical Testing Services Businesses

www.stocktitan.net/news/LH/labcorp-announce...

0 0 0 0

OPKO Health Swings to Profit: Can This Healthcare Turnaround Story Maintain Momentum? OPKO achieved profitability with $14M net income, strengthened its balance sheet with $431.9M cash, and advanced key pharmaceutical partnerships while reducing costs.

1 year ago

#OPK OPKO Health Reports Fourth Quarter 2024 Business Highlights and Financial Results

www.stocktitan.net/news/OPK/opko-health-rep...

0 0 0 0

1 year ago

🎯 Momentum #Options Activity trade ideas! Heavy institutional #optionsvolume far above daily average with strong consensus on direction.

AM Algo #TradeIdea from 🔥 INSIDERFINANCE.COM 🔥
#MO, #VRNA, #OPK, #GDRX, #BOX

#OptionFlow #OptionsTrading #Trading

0 0 0 0

1 year ago

🎯 #UnusualOptionsActivity trade ideas! Strong census from institutions on #options with short expirations.

AM Algo #TradeIdea from 🔥 INSIDERFINANCE.COM 🔥
#FUBO, #GRRR, #OPK, #BE, #CORZ

#OptionFlow #OptionsTrading #Trading

0 0 0 0

@smcapstrategist.bsky.social

1 year ago

🚨 Institutions #optionsvolume surge detected!

AM Top Momentum Activity from 🔥 INSIDERFINANCE.COM 🔥
1. #MO 7.0x
2. #VRNA 4.3x
3. #OPK 4.0x
4. #GDRX 3.7x
5. #AFRM 2.5x

#OptionFlow #OptionsTrading #Trading

0 0 0 0

Small Cap Strategist

1 year ago

SmCpStr Technicals – Technical Indicators for Small-cap Stocks

Most searched small-cap stocks, Mon Feb 10th - #KULR #MBOT #IVVD #QBTS #EH #BB #LAES #RR #LUNR #WULF #OPK #RXRX #POWL #DOMH #SMR #PLRX #PLYA #BDRX #MNTS #GERN - More: crystalequityresearch.com/SmCpStr/ - #smallcap

1 0 0 0

OPKO Health Begins First-Ever Phase 1 Trial of Epstein-Barr Virus Vaccine with Merck OPKO's ModeX unit launches groundbreaking clinical trial for EBV vaccine candidate MDX2201, targeting the virus linked to mono and cancers. First participant dosed in 200-person study.

1 year ago

#OPK OPKO Health’s ModeX Therapeutics Announces Epstein-Barr Virus Vaccine Candidate Enters Phase I Clinical Study in Collaboration with Merck

www.stocktitan.net/news/OPK/opko-health-s-m...

0 0 0 0

NextPlat Secures Major Deal: Approved to Sell OPKO Health Products on JD.com's Massive E-commerce Platform NextPlat gains access to 340M+ Chinese consumers through JD.com partnership, set to launch OPKO health products in growing $100B nutraceuticals market. Launch planned for Q1 2025.

1 year ago

#NXPL #OPK #NXPLW NextPlat Gains e-Commerce Access to Over 340 Million Consumers with Launch on JD.Com, China's Largest Online Retailer

#StockMarket #investing #news

www.stocktitan.net/news/NXPL/next-plat-gain...

0 0 0 0

1 year ago

#OPK OPKO Health to Participate in the Piper Sandler 36th Annual Healthcare Conference

www.stocktitan.net/news/OPK/opko-health-to-...

0 0 0 0

1 year ago

#NXPL #OPK #NXPLW NextPlat to Showcase OPKO Healthcare Products at the 2024 China International Natural Health & Nutrition Expo

www.stocktitan.net/news/NXPL/next-plat-to-s...

0 0 0 0

@willowstella98.bsky.social

1 year ago

🚨 Institutions #optionsvolume surge detected!

Weekly Top Momentum Activity from 🔥 INSIDERFINANCE.COM 🔥
1. #WAB 1108.4x
2. #MSM 160.8x
3. #TRMB 55.0x
4. #OPK 35.0x
5. #BHC 30.6x

#OptionFlow #OptionsTrading #Trading

0 0 0 0

Market Wire News

@marketwirenews.com

1 year ago

Just In: ( NASDAQ: #OPK ) Labcorp Completes Acquisition of Select Assets of BioReference Health's Diagnostics Business from OPKO Health

#StockMarket #News

1 0 0 0

Market Wire News

@marketwirenews.com

1 year ago

BREAKING NEWS: ( NASDAQ: #OPK ) Opko Health (OPK) Q2 2024 Earnings Call Transcript

#StockMarket #News

1 0 0 0

Willow Stella

1 year ago

Positive Ovulation Test When Pregnant: What You Need To Know?

#ovulationtest #ovulation #uptmurah #pregnancytestmurah #upt #ttc #pregnancytest #opkmurah #opk

www.ababyhandbook.com/pregnancy/po...

0 0 0 0

Market Wire News

@marketwirenews.com

1 year ago

News; ( NASDAQ: #OPK ) OPKO Health Announces $100 Million Share Repurchase Program

#StockMarket #News

0 0 0 0

MurakamiLoki ムラカミロキ

@nzchao.bsky.social

1 year ago

TikTok - Make Your Day

西荻窪で１人ゲワイしてますた。

#opk #CityHunter #シティハンター #NickyLarson #xyz #xygin #tmnetwork #getwild #ゲットワイルド
www.tiktok.com/@nzchao/vide...

0 0 0 0

1 year ago

🎯 Momentum #Options Activity trade ideas! Heavy institutional #optionsvolume far above daily average with strong consensus on direction.

PM Algo #TradeIdea from 🔥 INSIDERFINANCE.COM 🔥
#MO, #JCI, #DKS, #OPK, #AHCO

#OptionFlow #OptionsTrading #Trading

0 0 0 0